Early trial tests drug combos to help immune system fight advanced kidney cancer
NCT ID NCT02210117
Summary
This early-stage study is testing three different immunotherapy drug combinations in patients with advanced kidney cancer that has spread. The main goal is to see which combination is safest and causes the fewest side effects when given before surgery to remove the cancer. Researchers will also look at how the treatments affect the immune system and the cancer itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.